article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Collectively, private investors have poured billions of dollars into these companies, with more money coming from non-profit organizations. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way.

Law 105
article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

It became illegal in the US in 2009. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine.

History 119
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

And at last, in February 2009 a dual peak on a testing graph appeared, indicating the presence of CBD. “I By the summer of 2009, the lab had identified five strains with significant CBD and THC. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. And because of public demand, the F.D.A.

CBD 40
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Data collection. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. New York: Routledge; 2009. ML was responsible for the coding categories, data collection, and analysis. Entman RM, Matthes J, Pellicano L. Google Scholar. Entwistle V.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.